icer glp-1 ups value ceiling for Novo, Lilly obesity drugs as clinical benefits multiply GLP-1 drugs for obesity now
Description
It requires clinical oversight
A 1.0 mg dose would be only 10 units
The Boost by THINNR was engineered specifically for this population
[DOI] [PMC free article] [PubMed] [Google Scholar] 105.J.R
Danuglipron and lotiglipron both fell to liver signals, and Pfizer's experience has made the FDA and other agencies acutely sensitive to transaminase data in oral GLP-1 programs
